切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2019, Vol. 08 ›› Issue (02) : 93 -96. doi: 10.3877/cma.j.issn.2095-3259.2019.02.007

所属专题: 文献

专家论坛

妊娠期重症肌无力对母儿的影响及诊治
唐荣1, 李力2,()   
  1. 1. 400038 重庆,中国人民解放军陆军军医大学基础医学院四大队13队
    2. 400042 重庆,中国人民解放军特色医学中心妇产科中心
  • 收稿日期:2018-12-30 出版日期:2019-05-18
  • 通信作者: 李力

Diagnosis and treatment of myasthenia gravis during pregnancy and the effect on mother and child

Rong Tang1, Li Li2()   

  • Received:2018-12-30 Published:2019-05-18
  • Corresponding author: Li Li
引用本文:

唐荣, 李力. 妊娠期重症肌无力对母儿的影响及诊治[J/OL]. 中华产科急救电子杂志, 2019, 08(02): 93-96.

Rong Tang, Li Li. Diagnosis and treatment of myasthenia gravis during pregnancy and the effect on mother and child[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2019, 08(02): 93-96.

重症肌无力(myasthenia gravis,MG)常发生在20~45岁的育龄女性,病情变化常难以预测。妊娠合并MG轻症者可考虑继续妊娠,重症者应终止妊娠。妊娠期间应加强监护,维持病情的稳定,确保母亲及胎儿的安全。妊娠期间用药是安全的,临床常用的药物有抗胆碱酯酶药、免疫抑制剂和免疫球蛋白等。MG不是剖宫产的指征,可经阴道自然分娩。新生儿可能会出现一过性的肌无力,但往往是暂时的。

Myasthenia gravis (MG) often occurs in women of childbearing age between 20 to 45 years, and changes in MG′s condition during pregnancy are often difficult to predict. Continue pregnancy may be considered for pregnancy with MG mild cases, and severe cases should be terminated. During pregnancy, supervision should be strengthened to maintain the stability of the condition and ensure the safety of the mother and the fetus. It is safe to take anti-cholinesterase drugs, immunosuppressant and immunoglobulins for MG patients during pregnancy. In addition, MG is not an indication for cesarean section; it can be delivered naturally through the vagina. Newborns may have transient muscle weakness, but it is often temporary.

[1]
Shi BB, Zeng LC. Management of myasthenia gravis during pregnancy: A report of eight cases [J]. Open Life Sciences, 2018, 13(1): 28-33.
[2]
Bettini M, Chaves M, Cristiano E, et al. Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina [J]. Neuroepidemiology, 2017, 48(3-4): 119-123.
[3]
马艳艳,刘建军. 肌无力危象的治疗研究进展[J]. 医学信息,2019, 32(6): 45-47.
[4]
Waters J. Management of Myasthenia Gravis in Pregnancy [J]. Neurol Clin, 2019, 37(1): 113-120.
[5]
Hamel J, Ciafaloni E. An Update [J]. Neurologic Clinics, 2018, 36(2): 355-365.
[6]
Mays J, Butts CL.Intercommunication between the neuroendocrine and immune systems:focus on myasthenia gravis [J]. Neurol Clin, 2011, 18(5): 320-327.
[7]
Hoff JM, Daltveit AK, Gilhus NE. Asymptomatic myasthenia gravis influences pregnancy and birth [J]. Eur J Neurol, 2004, 11(8): 559-662.
[8]
华绍芳,韩玉环. 妊娠合并重症肌无力的临床研究进展[J]. 国际妇产科学杂志,2014, 41(3): 218-220.
[9]
Batocchi AP, Majolini L, Evofi A, et al. Course and treatment of myasthenia gravis during pregnancy[J]. Neurology, 1999, 52(3): 447-452.
[10]
Santos E, Braga A, Gabriel D, et al. MuSK myasthenia gravis and pregnancy [J]. Neuromuscul Disord, 2018, 28(2): 150-153.
[11]
Chaudhry SA, Vignarajah B, Koren G. Myasthenia gravis during pregnancy [J]. Can Fam Physician, 2012, 58(12): 1346-1349.
[12]
Ducci RD, Lorenzoni PJ, Kay CS, et al. Clinical follow-up of pregnancy in myasthenia gravis patients[J]. Neuromuscular Disorders, 2017, 27(4): 352-357.
[13]
Hassan A, Yasawy ZM. Myasthaenia Gravis: Clinical management issues before, during and after pregnancy [J]. Sultan Qaboos Univ Med J, 2017, 17(3):e259-e267.
[14]
Braga AC, Pinto C, Santos E, et al. Myasthenia gravis in pregnancy: Experience of a portuguese center[J]. Muscle Nerve, 2016, 54(4): 715-720.
[15]
Varner M. Myasthenia gravis and pregnancy [J]. Clin Obstet Gynecol, 2013, 56(2): 372-381.
[16]
Picone O, Audibert F, Gajdos P, et al. Myasthenia gravis and pregnancy:report of 13 cases [J]. J Gynecol Obstet Biol Reprod(Paris), 2003, 32(7): 654-659.
[17]
宋亦军,刘俊涛. MG对妊娠的影响及处理[J]. 中国实用妇科与产科杂志,2016, 32(10): 945-948.
[18]
Wen JC, Liu TC, Chen YH, et al. No increased risk of adverse Pregnancy outcomes for women with myasthenia gravis:a nationwide population-based study[J]. Eur J Neurol, 2009, 16(8): 889-894.
[19]
Saint-Faust M, Perelman S, Dupont D, et al. Transient neonatal Myasthenia gravis revealing a myasthenia gravis and a systemic lupus erythematosus in the mother:case report and review of the literature[J]. Am J Perinatol, 2010, 27(2): 107-110.
[20]
吴慧,朱雯华,刘华,等. 重症肌无力与妊娠[J]. 中国临床神经科学,2014, 22(6): 672-676.
[21]
Lee JY, Min JH, Han SH, et al. Transient neonatal myasthenia gravis due to a mother with ocular onset of anti-muscle specific kinase myasthenia gravis [J]. Neuromuscul Disord, 2017, 27(7): 655-657.
[22]
刘金林,孔丽娜. 妊娠期重症肌无力患者的临床研究进展[J]. 湖北科技学院学报(医学版), 2016, 30(2): 182-184.
[23]
Gilhus NE, Hong Y. Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence[J]. Eur J Neurol, 2018, 25(12): 1402-1409.
[24]
金得燕. 8例妊娠合并MG患者围生期护理[J]. 护理学杂志,2018, 33(19): 42-44.
[25]
Imai T, Suzuki S, Tsuda E, et al. Oral corticoid therapyand present disease status in myasthenia gravis [J]. Muscle Nerve, 2015, 51(5): 692-696.
[26]
Gilhus NE, Hong Y. Successful early treatment with intravenous immunoglobulin for seronegative myasthenia gravis with onset during pregnancy: A case report[J]. Eur J Neurol, 2016, 4(6): 228-229.
[27]
胡华林. 大剂量静注免疫球蛋白对危重重症肌无力的疗效观察[J]. 深圳中西医结合杂志,2015(2): 108-109.
[28]
Gamez J, Salvado M, Casellas M, et al. Intravenous immunoglobulin as monotherapy for myasthenia gravis during pregnancy [J]. J Neurol Sci, 2017, 383: 118-122.
[29]
许啟伍,丁婷. 重症肌无力的治疗进展[J]. 实用临床医学,2016, 17(7): 104-107.
[30]
Chaudhry SA, Vignarajah B, Koren G. Myasthenia gravis during pregnancy [J]. Can Fam Physician, 2012, 58(12): 1346-1349.
[31]
陈顿,彭丹涛,钱璐璐,等.药物对重症肌无力的影响[J]. 中国神经免疫学和神经病学杂志,2015, 22(1): 71-75.
[32]
Roth CK, Dent S, McDevitt K. Myasthenia gravis in pregnancy[J]. Nurs Womens Health, 2015, 19(3): 248-252.
[33]
李海峰. 重症肌无力患者的妊娠管理:英国多学科共同制定的临床实践指南[J]. 中国神经免疫学和神经病学杂志,2014, 21(3): 228-229.
[1] 李钱梅, 何冠南, 赵婧, 陈曦, 唐玉英, 马丽琼, 梁蓉, 袁桃, 李明星. 早孕期低危妊娠和高危妊娠胎盘微血流成像特征及预后分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 726-732.
[2] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[3] 刘子洋, 崔俭俭, 赵茵. 产科弥散性血管内凝血及其评分系统的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 511-518.
[4] 谢江燕, 王亚菲, 贺芳. 妊娠合并血栓性血小板减少性紫癜2例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 556-563.
[5] 石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[6] 韩肖燕, 杨桦. 中孕期孕妇血清胎盘生长因子水平低与胎儿不良预后的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 398-402.
[7] 杜佳丽, 鲍睿, 乔春红, 韩伟. 中孕期宫颈功能不全孕妇经阴道紧急宫颈环扎术后不良妊娠结局预测模型构建[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 403-409.
[8] 张静, 刘畅, 华成舸. 妊娠期患者口腔诊疗进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(05): 340-344.
[9] 王岩, 钱宏阳, 朱寅杰, 董柏君, 潘家骅, 薛蔚. 机器人辅助单孔腹膜外根治性前列腺切除治疗高危前列腺癌的瘤控效果初探[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 435-440.
[10] 李想, 郭征, 田洪哲, 李杜, 熊梦瑶, 潘铁军. 1 470 nm半导体激光减容性切除治疗高危前列腺增生的临床研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 448-452.
[11] 刘静, 徐爽, 缪亚军. 肺腺癌miR-3653表达与高危型人乳头瘤病毒感染及预后的关系[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 600-604.
[12] 徐敬云, 丁波, 蒋宇慧, 沈杨. 妊娠期单孔腹腔镜手术实施行与思[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 262-266.
[13] 胡小靖, 张华. 妊娠期卵巢囊肿蒂扭转的诊断与治疗[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 197-201.
[14] 黎璞, 生秀杰. 妊娠合并子宫颈癌的管理[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 202-208.
[15] 杭中霞, 王朝霞, 孙琴, 李妮. 血清Irisin、TSH 及Hcy 在妊娠期甲状腺功能减退症诊断中的应用[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 265-269.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?